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ABSTRACT 
Objectives: The aim of the present study was to synthesize a series of new lignan intermediates as potential antimicrobial agents. 
Methods: Substituted benzene and aromatic acids or acid chlorides were converted to benzophenones 1(a-f). The benzophenones 1(a-f) on Stobbe 
condensation with and diethyl succinate in the presence of potassium t-butoxide yielded 4-(4-aryl)-4-(4-aryl)-3-ethoxycarbonyl-but-3-enoic acids 
(2a, 2f) and a mixture of E and Z-isomers of 4,4-diaryl-3-ethoxycarbonyl-but-3-enoic acids 2(b-e) and 3(b-e) in relatively good yields. The 
synthesized compounds were tested for their antimicrobial susceptibility against different fungi and bacteria species.  
Results: The Stobbe condensation of benzophenones 1(a-f) and diethyl succinate in the presence of potassium t-butoxide yielded 4-(4-aryl)-4-(4-
aryl)-3-ethoxycarbonyl-but-3-enoic acids (2a, 2f) and a mixture of E and Z-isomers of 4,4-diaryl-3-ethoxycarbonyl-but-3-enoic acids 2(b-e) and 3(b-
e) in good yields. The compounds 1a and 1f yielded only 2a and 2f but not 3a and 3f due to symmetrical substitution in the aromatic rings. The 
structures of the new lignan intermediates were confirmed by spectral studies and elemental analysis.  
Conclusions: Results of the antimicrobial activity reveal that some of the compounds particularly 2c, 2d, 3c and 3d act as potential antimicrobial 
agents different fungal and bacterial organisms.  
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INTRODUCTION 
The lignans are a group of secondary metabolites found in plants, 
which are produced by oxidative dimerization of two phenyl 
propanoid units and show bioactive diversity as their chemical 
assembly. The range of their structures and biological activities is 
broad. Various lignans are known to have anti-tumour, antimitotic 
and antiviral activity and to specifically inhibit certain enzymes. 
Novel lignans continue to be described by natural products chemists 
at a steady rate and knowledge of their variety, as well as their range 
of occurrence in the plant kingdom, is continually expanding [1]. 
Thiophene-based lignan analogues were synthesized by a selective 
and high performance synthetic strategy based on the Negishi cross-
coupling reaction [2]. An enantiomerically pure α-hydroxylated 
lactone lignans were synthesized starting from diisopropyl malate, 
which involve stereo selective alkylation with various benzyl 
bromides and saponification yielded the corresponding succinic 
acids. Acetalization afforded the dioxolanones, which were stereo 
selectively alkylated [3].  
1-Phenyl-1H-benzo[b]azepine-2,5 dione was prepared by an 
intramolecular cyclisation of 4-N,N-diphenylamine-4-oxo-2-butenoic 
acid in good yield showed considerable activity against F. Solani and 
A. Flavus fungal strains [4]. Several reviews on lignan synthesis have 
been published, among them a recent reviews describe the synthetic 
strategies adopted for the synthesis of lignans and their scaffolds [5-
6]. An asymmetric and regioselective total synthesis approach to 
1,4-benzodioxane lignans in which (2R, 3R)-and (2S,3S)-3-(4-
hydroxy-3-methoxyphenyl)-2-hydroxymethyl-1,4-benzodioxan-6-
carbaldehyde were reported [7]. Intramolecular cyclization via 
nitrenium ion of 2-phenylpentanoic/2-phenylbutanoic acid esters 
with a terminal p-azidophenyl group gives direct access to 
tetrahydronaphthalene lignan esters, which showed good anti-
tumor activity against cell lines MCF-7, NCI-H460, SF-268 and UACC-
62 [8].  
In view of enormous biological applications associated with lignan 
analogues, we herein report the stereoselective synthesis of lignan 
intermediates and their antimicrobial activity studies.  
Experimental  
Melting points were determined by open capillary method and are 
uncorrected. IR spectra were recorded on a Nujol mull on Shimadzu 
8300 spectrometer. 1H NMR and 13C NMR spectra were recorded on 
Agilent-NMR 400 MHz and 100 MHz spectrophotometer 
respectively in CDCl3 with TMS as an internal standard. The chemical 
shifts are expressed in δ ppm. Mass spectra were obtained on Mass 
Lynx SCN781 spectro photomer TOF mode. Elemental analysis was 
performed on a Thermo Finnigan Flash EA 1112 CHN analyzer. 
Chromatographic separations were carried out on silica gel (70-230 
mesh, Merck) column using hexane: ethyl acetate (6:2 v/v) as eluent. 
 
 
Scheme 1: Synthetic route for lignin intermediates 
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In a typical procedure, substituted benzene and aromatic acids or 
acid chlorides were converted to benzophenones 1(a-f) using PPA or 
AlCl3. The Stobbe condensation of benzophenones 1(a-f) and diethyl 
succinate in the presence of a strong base potassium t-butoxide 
yielded 4-(4-aryl)-4-(4-aryl)-3-ethoxycarbonyl-but-3-enoic acids 
(2a, 2f) and a mixture of E and Z-isomers of 4,4-diaryl-3-
ethoxycarbonyl-but-3-enoic acids 2(b-e) and 3(b-e) in relatively 
good yields (Scheme-1). 
Antimicrobial activity of the synthesized compounds was done by 
paper disc diffusion method [9-11]. The bacteria species Escherichia 
coli, Bacillus substilis, Staphylococcus aureus and fungal species 
Aspergillus niger, Aspergillus flavus, Fusarium oxysporium were used 
as test stains. Briefly a lawn of the organism was prepared by 
spreading 50 ml of overnight cultures (conc. 106∼107 CFU/ml) onto 
agar set in petri dishes. Sterile filter paper discs containing test 
compounds 2(a-f) and 3(b-e) at the concentration of 50 µg/ml in 
methanol/water are placed at equal distances on the agar plate. 
Control experiments with equivalent volumes of the only solvent 
were applied to the paper discs. The standard drugs ciprofloxacin 
(25 µg/disc) and nystatin (25 µg/disc) were used as the positive 
control against bacteria and fungi organisms. Plain dry discs were 
used as negative controls. The plates were incubated at 37 °C for 24 
h to check clearing zones around the discs. Clearing zones around 
the disc (zone of inhibition) were measured as diameter in mm. The 
screening tests were carried out in triplicate and the results were 
expressed as a mean of three determinations±Standard Deviation 
(SD).  
Preparation of poly phosphoric acid (PPA) 
Initially reagent grade orhopolyphosphoric acid (85 ml) was heated 
for half an hour to remove traces of water present in it. Phosphorous 
pentoxide (100 g) was taken in a 250 ml three-necked flask and then 
the flask equipped with a mechanical stirrer, mercury seal tube and 
guard tube. The hot orhopolyphosphoric acid (75 ml) was added to 
phosphorous pentoxide and the mixture was vigorously stirred by 
maintaining the temperature between 170-200 °C. The whole 
mixture became a clear viscous liquid. The solid lump left over was 
removed by means of spatula and the liquid was stirred for again for 
1 h and cooled to 90-100 °C. 
Typical procedure for the synthesis of substituted 
benzophenone, 1a 
Ethoxybenzene (0.15 mol) was slowly added to the freshly prepared 
PPA at 80 °C with swirling and the mixture was stirred for 15 min. 4-
Ethoxybenzoic acid (0.15 mol) was added at a stretch and the 
mixture was vigorously stirred for 3 h on a oil bath at 90-100 °C. 
After the completion of the reaction, the mixture was cooled to room 
temperature and was poured into ice (250 g) with stirring. The dark 
grey colored precipitate formed was filtered, the residue is digested 
with 10% sodium hydroxide (100 ml) for half an hour using 
mechanical stirrer and filtered again. The solid obtained was 
repeatedly washed with water to free alkali and then recrystallized 
from alcohol to get bis (4-ethoxyphenyl) methanone in 74% yield. 
Alternatively, the substituted benzophenone, 1a was prepared 
by alternative procedure as follows 
A mixture of aluminium chloride (0.01 mmol) and ethoxybenzene 
(0.01 mmol) in dry carbon disulphide (50 ml) was stirred at 5 °C for 
1 hour. 4-Ethoxybenzoyl chloride (0.01 mmol) was added to the 
reaction mixture slowly with swirling. Then the mixture was then 
stirred for 6h at room temperature. The reddish brown mixture 
obtained was acidified with 5N HCl and extracted into diethyl ether 
(3×25 ml). The organic layer washed successively with 10% sodium 
hydroxide (3×25 ml) and water (3×25 ml). The organic layer was 
evaporated to dryness. The crude solid was recrystallized from 
ethanol to get bis(4-ethoxyphenyl) methanone in 56% yield. The 
same procedure was used in all cases. 
General procedure for the synthesis of 4-(4-ethoxyphenyl)-4-
(4-ethoxyphenyl)-3-ethoxycarbonyl-but-3-enoic acid (2a) 
To freshly prepared potassium t-butoxide [from potassium (0.09 
mol) and t-butanol (120 ml)], 4,4’-diethoxy benzophenone 1a (0.09 
mol) was added quickly under nitrogen atmosphere and refluxed for 
1 h. Then freshly distilled diethyl succinate was added under 
nitrogen atmosphere and refluxed for 30 h. The progress of the 
reaction was monitored by TLC. After the completion of the reaction, 
the excess of t-butanol was removed by distillation under reduced 
pressure. The resulting residual mass was acidified with 5N HCl. The 
product was extracted into 10% NaHCO3 (3×150 ml) solution and 
washed with diethyl ether (3×150 ml) and then acidified with 10% 
HCl. The resulting mass was recrystallized from methyl alcohol to 
get 2a in 78% yield. The same procedure was used for the synthesis 
of 2f from 1f. 
General procedure for the synthesis of 4,4-diaryl-3-ethoxycarbonyl-
but-3-enoic acids To freshly prepared potassium t-butoxide, 4,4’-
diaryl benzophenone 1(b-e) (0.09 mol) was added quickly under 
nitrogen atmosphere and refluxed for 1 h. Then freshly distilled 
diethyl succinate was added under nitrogen atmosphere and 
refluxed for 30 h. The progress of the reaction was monitored by 
TLC. After the completion of the reaction, the excess of t-butanol was 
removed by distillation under reduced pressure. The resulting 
residual mass was acidified with 5N HCl. The product was extracted 
into 10% NaHCO3 (3×150 ml) solution and washed with diethyl 
ether (3×150 ml) and then acidified with 10% HCl. The reaction 
furnished a mixture of E and Z-isomers of 4,4-diaryl-3-
ethoxycarbonyl-but-3-enoic acids 2(b-e) and 3(b-e) in good yields. 
The isomers were separated by column chromatography. The E and 
Z-isomers are obtained due to the asymmetric substitution in the 
two aromatic rings.  
RESULTS AND DISCUSSION 
3-(Ethoxycarbonyl)-4,4-bis(4-ethoxyphenyl)but-3-enoic acid, 
2a 
Obtained from bis(4-ethoxyphenyl) methanone (1a) and diethyl 
succinate in 62% yield, m. p. 112-115 °C. IR (Nujol, γ cm-1): 3030 (b) 
(OH str), 1748 (s) (ester C=O str), 1725 (s) (acid C=O str), 1667 (w) 
(C=C str), 1226 (s) (C-O str). 1HNMR (CDCl3): δ 1.202 (t, 3H, CH3), 
1.310 (t, 6H, CH3), 3.640 (s, 2H, CH2), 4.080 (q, 4H, OCH2), 4.236 (q, 
2H, OCH2), 6.984 (dd, 4H, Ar-H), 7.222 (dd, 4H, Ar-H), 10.556 (s, 1H, 
COOH).13C NMR (CDCl3): δ14.04 (1C, CH3), 14.66 (2C, CH3), 35.18 
(1C, C-2), 61.26 (1C, OCH2), 63.40 (2C, OCH2), 114.20 (4C, Ar-C), 
115.72 (1C, C-3), 128.94 (4C, Ar-C), 132.16 (2C, Ar-C), 157.38 (2C, Ar-
C), 158.41 (1C, C-4), 168.30 (1C, COO), 174.14 (1C, COOH). MS 
(m/z): 398 (M+, 22), 370 (24), 326 (36), 308 (100), 280 (42), 252 
(54). Anal. Calcd. for C23H26O6: C, 69.33; H, 6.58%; Found: C, 69.12; H, 
6.51%.  
(E)-3-(Ethoxycarbonyl)-4-(4-ethoxyphenyl)-4-(4-
methoxyphenyl)but-3-enoic acid, 2b 
Obtained from (4-ethoxyphenyl)(4-methoxyphenyl) methanone 
(1b) and diethyl succinate in 60% yield, m. p. 101-104 °C. IR (Nujol, 
γ cm-1): 3022 (b) (OH str), 1745 (s) (ester C=O str), 1724 (s) (acid 
C=O str), 1665 (w) (C=C str), 1225 (s) (C-O str). 1HNMR (CDCl3): δ 
1.210 (t, 3H, CH3), 1.324 (t, 3H, CH3), 3.668 (s, 2H, CH2), 3.853 (s, 3H, 
OCH3), 4.123 (q, 2H, OCH2), 4.254 (q, 2H, OCH2), 6.978 (dd, 4H, Ar-
H), 7.241 (dd, 4H, Ar-H), 10.598 (s, 1H, COOH). 13C NMR (CDCl3): 
δ14.10 (1C, CH3), 14.68 (1C, CH3), 35.18 (1C, C-2), 55.82 (1C, OCH3), 
61.20 (1C, OCH2), 63.76 (1C, OCH2), 114.28 (4C, Ar-C), 115.80 (1C, C-
3), 128.90 (4C, Ar-C), 132.56 (2C, Ar-C), 157.40 (2C, Ar-C), 158.66 
(1C, C-4), 169.04 (1C, COO), 174.40 (1C, COOH). MS (m/z): 384 (M+, 
25), 356 (30), 312 (28), 294 (100), 266 (51). Anal. Calcd. for 
C22H24O6: C, 68.74; H, 6.29%; Found: C, 68.62; H, 6.10%.  
(Z)-4-(3,4-Dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-
ethoxyphenyl)but-3-enoic acid, 2c 
Obtained from (3,4-dimethoxyphenyl)(4-ethoxyphenyl) methanone 
(1c) and diethyl succinate in 52% yield, m. p. 96-97 °C. IR (Nujol, γ 
cm-1): 3000 (b) (OH str), 1740 (s) (ester C=O str), 1721 (s) (acid C=O 
str), 1668 (w) (C=C str), 1220 (s) (C-O str). 1HNMR (CDCl3): δ 1.208 
(t, 3H, CH3), 1.356 (t, 3H, CH3), 3.555 (s, 2H, CH2), 3.866 (s, 6H, 
OCH3), 4.008 (q, 2H, OCH2), 4.212 (q, 2H, OCH2), 6.901-7.240 (m, 7H, 
Ar-H), 10.721 (s, 1H, COOH). 13C NMR (CDCl3): δ14.14 (1C, CH3), 
14.71 (1C, CH3), 35.26 (1C, C-2), 55.90 (2C, OCH3), 61.26 (1C, OCH2), 
63.67 (1C, OCH2), 109.19 (1C, Ar-C), 112.04 (1C, Ar-C), 114.20 (2C, 
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Ar-C), 115.92 (1C, C-3), 122.30 (1C, Ar-C), 129.06 (2C, Ar-C), 133.14 
(1C, Ar-C), 132.88 (1C, Ar-C), 148.70 (2C, Ar-C), 157.12 (1C, Ar-C), 
159.34 (1C, C-4),168.54 (1C, COO), 174.88 (1C, COOH). MS (m/z): 
414 (M+, 24), 386 (33), 342 (28), 324 (100), 296 (47). Anal. Calcd. 
for C23H26O7: C, 66.65; H, 6.32%; Found: C, 66.45; H, 6.22%.  
(Z)-4-(3,4-Dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-
methoxyphenyl)but-3-enoic acid, 2d 
Obtained from (3,4-dimethoxyphenyl) (4-methoxyphenyl) 
methanone (1d) and diethyl succinate in 53% yield, m. p. 115-117 
°C. IR (Nujol, γ cm-1): 3015 (b) (OH str), 1742 (s) (ester C=O str), 
1721 (s) (acid C=O str), 1667 (w) (C=C str), 1200 (s) (C-O str). 
1HNMR (CDCl3): δ 1.221 (t, 3H, CH3), 3.604 (s, 2H, CH2), 3.850 (s, 9H, 
OCH3), 4.128 (q, 2H, OCH2), 6.889-7.312 (m, 7H, Ar-H), 10.703 (s, 1H, 
COOH). 13C NMR (CDCl3): δ14.34 (1C, CH3), 34.98 (1C, C-2), 55.85 
(3C, OCH3), 61.44 (1C, OCH2), 109.12 (1C, Ar-C), 112.30 (1C, Ar-C), 
114.28 (2C, Ar-C), 115.98 (1C, C-3), 121.96 (1C, Ar-C), 129.10 (2C, 
Ar-C), 133.20 (2C, Ar-C), 148.82 (2C, Ar-C),157.40 (1C, Ar-C), 158.56 
(1C, C-4), 168.50 (1C, COO), 174.67 (1C, COOH). MS (m/z): 400 (M+, 
18), 372 (30), 328 (40), 310 (100). Anal. Calcd. for C22H24O7: C, 
65.99; H, 6.04%; Found: C, 65.78; H, 6.12%.  
(Z)-3-(Ethoxycarbonyl)-4-(3-methoxyphenyl)-4-(4-methoxy 
phenyl) but-3-enoic acid, 2e 
Obtained from (3-methoxyphenyl)(4-methoxyphenyl) methanone 
(1e) and diethyl succinate in 55% yield, m. p. 122-124 °C. IR (Nujol, 
γ cm-1): 2980 (b) (OH str), 1743 (s) (ester C=O str), 1714 (s) (acid 
C=O str), 1668 (w) (C=C str), 1188 (s) (C-O str). 1HNMR (CDCl3): δ 
1.218 (t, 3H, CH3), 3.618 (s, 2H, CH2), 3.862 (s, 6H, OCH3), 4.131 (q, 
2H, OCH2), 6.894-7.402 (m, 8H, Ar-H), 10.733 (s, 1H, COOH). 13C NMR 
(CDCl3): δ14.20 (1C, CH3), 34.52 (1C, C-2), 55.88 (2C, OCH3), 61.40 
(1C, OCH2), 111.10 (1C, Ar-C), 112.76 (1C, Ar-C), 114.24 (2C, Ar-C), 
115.12 (1C, C-3), 119.62 (1C, Ar-C), 129.14 (2C, Ar-C), 130.16 (1C, 
Ar-C), 133.21 (1C, Ar-C), 140.02 (1C, Ar-C), 157.66 (1C, Ar-C), 158.51 
(1C, C-4), 160.62 (1C, Ar-C), 168.22 (1C, COO), 174.60 (1C, COOH). 
MS (m/z): 370 (M+, 28), 342 (36), 298 (48), 280 (100). Anal. Calcd. 
for C21H22O6: C, 68.10; H, 5.99%; Found: C, 68.01; H, 5.83%. 
4,4-Bis(4-bromophenyl)-3-(ethoxycarbonyl)but-3-enoic acid, 2f 
Obtained from bis (4-bromophenyl) methanone (1f) and diethyl 
succinate in 58% yield, m. p. 133-135 °C. IR (Nujol, γ cm-1): 2975 (b) 
(OH str), 1740 (s) (ester C=O str), 1718 (s) (acid C=O str), 1669 (w) 
(C=C str), 1176 (s) (C-O str). 1HNMR (CDCl3): δ 1.266 (t, 3H, CH3), 
3.601 (s, 2H, CH2), 4.122 (q, 2H, OCH2), 7.118 (dd, 4H, Ar-H), 7.501 
(dd, 4H, Ar-H), 10.796 (s, 1H, COOH). 13C NMR (CDCl3): δ14.26 (1C, 
CH3), 34.20 (1C, C-2), 61.74 (1C, OCH2), 115.34 (1C, C-3), 121.42 (2C, 
Ar-C), 128.64 (4C, Ar-C), 131.50 (4C, Ar-C), 140.14 (2C, Ar-C), 158.44 
(1C, C-4), 167.69 (1C, COO), 174.14 (1C, COOH). Anal. Calcd. for 
C19H16Br2O4: C, 68.10; H, 5.99%; Found: C, 68.01; H, 5.83%. 
(Z)-3-(ethoxycarbonyl)-4-(4-ethoxyphenyl)-4-(4-methoxy 
phenyl) but-3-enoic acid, 3b 
Obtained from (4-ethoxyphenyl)(4-methoxyphenyl)methanone (1b) 
and diethyl succinate in 38% yield, m. p. 87-89 °C. IR (Nujol, γ cm-1): 
2920 (b) (OH str), 1736 (s) (ester C=O str), 1700 (s) (acid C=O str), 
1669 (w) (C=C str), 1112 (s) (C-O str). 1HNMR (CDCl3): δ 1.212 (t, 
3H, CH3), 1.326 (t, 3H, CH3), 3.670 (s, 2H, CH2), 3.858 (s, 3H, OCH3), 
4.126 (q, 2H, OCH2), 4.234 (q, 2H, OCH2), 6.986 (dd, 4H, Ar-H), 7.278 
(dd, 4H, Ar-H), 10.698 (s, 1H, COOH). 13C NMR (CDCl3): δ14.18 (1C, 
CH3), 14.51 (1C, CH3), 35.10 (1C, C-2), 55.88 (1C, OCH3), 61.40 (1C, 
OCH2), 63.70 (1C, OCH2), 114.46 (4C, Ar-C), 115.65 (1C, C-3), 128.35 
(4C, Ar-C), 132.58 (2C, Ar-C), 157.22 (2C, Ar-C), 158.34 (1C, C-4), 
169.54 (1C, COO), 174.44 (1C, COOH). MS (m/z): 384 (M+, 33), 356 
(52), 338 (100), 310 (46). Anal. Calcd. for C22H24O6: C, 68.74; H, 
6.29%; Found: C, 68.46; H, 6.22%.  
(E)-4-(3,4-Dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-ethoxy 
phenyl)but-3-enoic acid, 3c 
Obtained from (3,4-dimethoxyphenyl)(4-ethoxyphenyl) methanone 
(1c) and diethyl succinate in 44% yield, m. p. 141-143 °C. IR (Nujol, 
γ cm-1): 2935 (b) (OH str), 1739 (s) (ester C=O str), 1708 (s) (acid 
C=O str), 1668 (w) (C=C str), 1198 (s) (C-O str). 1HNMR (CDCl3): δ 
1.210 (t, 3H, CH3), 1.342 (t, 3H, CH3), 3.543 (s, 2H, CH2), 3.812 (s, 6H, 
OCH3), 4.108 (q, 2H, OCH2), 4.234 (q, 2H, OCH2), 6.944-7.222 (m, 7H, 
Ar-H), 10.739 (s, 1H, COOH). 13C NMR (CDCl3): δ14.09 (1C, CH3), 
14.86 (1C, CH3), 34.66 (1C, C-2), 55.84 (2C, OCH3), 61.31 (1C, OCH2), 
63.60 (1C, OCH2), 110.10 (1C, Ar-C), 112.16 (1C, Ar-C), 114.45 (2C, 
Ar-C), 115.88 (1C, C-3), 122.78 (1C, Ar-C), 129.86 (2C, Ar-C), 132.84 
(1C, Ar-C), 132.80 (1C, Ar-C), 148.90 (2C, Ar-C), 157.33 (1C, Ar-C), 
159.39 (1C, C-4), 168.51 (1C, COO), 174.80 (1C, COOH). MS (m/z): 
414 (M+, 20), 386 (18), 368 (100), 340 (43). Anal. Calcd. for C23H26O7: 
C, 66.65; H, 6.32%; Found: C, 66.42; H, 6.14%.  
(E)-4-(3,4-Dimethoxyphenyl)-3-(ethoxycarbonyl)-4-(4-
methoxyphenyl)but-3-enoic acid, 3d 
Obtained from (3,4-dimethoxyphenyl)(4-methoxyphenyl) 
methanone (1d) and diethyl succinate in 45% yield, m. p. 118-119 
°C. IR (Nujol, γ cm-1): 2943 (b) (OH str), 1737 (s) (ester C=O str), 
1710 (s) (acid C=O str), 1669 (w) (C=C str), 1184 (s) (C-O str). 
1HNMR (CDCl3): δ 1.230 (t, 3H, CH3), 3.624 (s, 2H, CH2), 3.858 (s, 9H, 
OCH3), 4.120 (q, 2H, OCH2), 6.870-7.340 (m, 7H, Ar-H), 10.770 (s, 1H, 
COOH). 13C NMR (CDCl3): δ14.38 (1C, CH3), 34.72 (1C, C-2), 55.86 
(3C, OCH3), 61.40 (1C, OCH2), 109.66 (1C, Ar-C), 112.09 (1C, Ar-C), 
114.55 (2C, Ar-C), 115.75 (1C, C-3), 121.44 (1C, Ar-C), 129.19 (2C, 
Ar-C), 133.23 (2C, Ar-C), 148.68 (2C, Ar-C), 157.57 (1C, Ar-C), 158.59 
(1C, C-4), 168.70 (1C, COO), 174.61 (1C, COOH). MS (m/z): 400 (M+, 
41), 372 (24), 354 (100). Anal. Calcd. for C22H24O7: C, 65.99; H, 
6.04%; Found: C, 65.86; H, 6.10%. 
(E)-3-(Ethoxycarbonyl)-4-(3-methoxyphenyl)-4-(4-
methoxyphenyl) but-3-enoic acid, 3e 
Obtained from (3-methoxyphenyl)(4-methoxyphenyl) methanone 
(1e) and diethyl succinate in 41% yield, m. p. 119-121 °C. IR (Nujol, 
γ cm-1): 2934 (b) (OH str), 1738 (s) (ester C=O str), 1712 (s) (acid 
C=O str), 1668 (w) (C=C str), 1202 (s) (C-O str). 1HNMR (CDCl3): δ 
1.220 (t, 3H, CH3), 3.602 (s, 2H, CH2), 3.865 (s, 6H, OCH3), 4.140 (q, 
2H, OCH2), 6.887-7.433 (m, 8H, Ar-H), 10.754 (s, 1H, COOH). 13C NMR 
(CDCl3): δ14.22 (1C, CH3), 34.56 (1C, C-2), 55.84 (2C, OCH3), 61.46 
(1C, OCH2), 111.67 (1C, Ar-C), 112.70 (1C, Ar-C), 114.92 (2C, Ar-C), 
115.86 (1C, C-3), 119.60 (1C, Ar-C), 129.74 (2C, Ar-C), 130.56 (1C, 
Ar-C), 132.26 (1C, Ar-C), 140.32 (1C, Ar-C), 157.61 (1C, Ar-C), 158.82 
(1C, C-4), 160.93 (1C, Ar-C), 168.37 (1C, COO), 174.63 (1C, COOH). 
MS (m/z): 370 (M+, 45), 342 (26), 324 (100). Anal. Calcd. for 
C21H22O6: C, 68.10; H, 5.99%; Found: C, 68.16; H, 5.81%. 
Structure proofs of the synthesized new compounds were provided 
by IR, 1H NMR, 13C NMR, MS studies and elemental analysis. The 
stretching frequencies in the IR spectrum of the compounds 2(a-f) 
and 3(b-e) showed a strong absorption bands in the region 1748-
1736 cm-1and 1725-1700 cm-1 for ester and acid C=O bonds 
respectively. A strong and intense absorption band absorbed in the 
region 1226-1112 cm-1was assigned to C-O bonds. A broad 
absorption band in the region 3030-2920 cm-1 and weak band in the 
region 1667-1669 cm-1 were assigned to-OH and C=C stretching 
respectively. 
In 1H NMR spectra, the compounds 2(a-f) showed a consistent 
pattern signals due to COOH protons as singlets in the region δ 
10.556-10.796 ppm., CH2 protons of the side chain in the region δ 
3.555-3.668 ppm. While the compounds 3(b-e) showed a consistent 
pattern signals due to COOH protons as singlets in the region δ 
10.698-10.770 ppm., two CH2 protons of side chain in the region δ 
3.543-3.670 ppm, respectively. All these compounds showed signals 
due to aromatic and substituent protons in the expected region. 
The structural assignments for the compounds 2(a-f) were made by 
13C NMR analysis by considering (E)-3-(ethoxycarbonyl)-4-(4-
ethoxyphenyl)-4-(4-methoxyphenyl)but-3-enoic acid, 2b as the 
representative compound. In its 13C NMR spectra, signals appeared 
at δ 174.40 ppm., δ 169.04 ppm were assigned to–COOH and–COO 
carbons respectively. The signals appeared at δ 35.18 ppm., δ 115.80 
ppm. and δ 158.66 ppm., were assigned to C-2, C-3 and C-4 carbons. 
The signals observed at δ 14.10, 14.68, 55.82, 62.20 and 63.76 ppm 
were assigned to the two CH3, OCH3 and two OCH3 carbons. Further, 
an array of signals observed at δ 114.28 ppm, 128.90 ppm, 132.56 
ppm and 157.44 ppm were assigned to aromatic carbon atoms fig.1. 
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Fig. 1: Carbon chemical shifts and couplings of 2b 
 
In 13C NMR, the compounds 3(a-e) showed a consistent pattern 
signals due to C-2, C-3 and C-4 carbons in the region δ 34.56-35.10 
ppm., δ 115.65-115.88 ppm., and δ 158.34-159.39 ppm. While the 
signals due to COOH, COO of ester carbons in the region δ 174.44-
174.80 ppm., δ 168.37-169.51 ppm respectively. Further they 
showed the signals due to the aromatic ring and in substituent 
carbons at the expected region.  
Significantly stable molecular ion peaks were observed in mass 
spectra of synthesized compounds. The common possible 
fragmentation involves with the removal of CH2=CH2, CO2, and H2O 
etc. The compound 2(a-f) showed their base peaks at (M-90), while 
the compounds 3(b-e) showed the base peaks at (M-46). These 
spectral studies confirm the structures of the synthesized new 
products. Further their structures were supported by satisfactory 
elemental analysis. 
The results of antifungal activity of the synthesized compounds 2(a-
f) and 3(b-e) tested against different bacteria species were 
summarized in fig.2. 
 
 
Fig. 2: Antibacterial activity of the synthesized compounds 2(a-f) and 3(b-e) at a concentration of 50 µg/ml in methanol/water tested 
against the bacterial strains. [Ciprofloxacin=25 µg/disc] 
 
The antibacterial activity results of the synthesized compounds 2(a-f) 
and 3(b-e) revealed that all compounds exerted moderate to excellent 
activity against the tested organisms, except 4,4-bis(4-bromophenyl)-3-
(ethoxycarbonyl)but-3-enoic acid 2f, that contain a bromo substitution 
on both the aromatic ring showed very poor inhibition against all the 
tested organisms. The compounds 2c, 2d, 3c and 3d which contain a 
strong electron donating OCH3 substitution showed excellent activity in 
comparison with the standard. The compounds 2a, 2b and 3b showed 
good, while the compounds 2e and 3e moderate antibacterial activity 
against the tested organisms. The results of antifungal activity of the 
synthesized compounds 2(a-f) and 3(b-e) tested against different fungi 
species were summarized in fig.3. 
  
 
Fig. 3: Antifungal activity of the synthesized compounds 2(a-f) and 3(b-e) tested against the fungal strains [Nystatin=25 µg/disc] 
 
The antibacterial activity results of the synthesized compounds 2(a-
f) and 3(b-e) revealed that all compounds exerted moderate to 
excellent activity against A. niger and A. flavus. However, all showed 
poorer activity against F. oxysporium organism. The compound 4,4-
bis(4-bromophenyl)-3-(ethoxycarbonyl)but-3-enoic acid 2f, that 
contain a bromo substitution showed very poor inhibition against all 
the tested organisms. The compounds 2c, 2d, 3c and 3d which 
contain a strong electron donating OCH3 substitution showed 
excellent activity in comparison with the standard against A. niger 
and A. flavus. The compounds 2a, 2b and 3b showed good, while the 
compounds 2e and 3e moderate antibacterial activity against the A. 
niger and A. flavus organisms. 
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CONCLUSION 
The accessible procedure for the synthesis of 4-(4-aryl)-4-(4-aryl)-
3-ethoxycarbonyl-but-3-enoic acids (2a, 2f) and a mixture of E and 
Z-isomers of 4,4-diaryl-3-ethoxycarbonyl-but-3-enoic acids 2(b-e) 
and 3(b-e) in relatively good yields and efficacy of some of the 
molecules as antimicrobial agents validates the significance of this 
study. Among the series, the compounds 2c, 2d, 3c and 3d acts as 
potential antifungal and antibacterial agents.  
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